| Process: |
GO:71456; cellular response to hypoxia
GO:2000773; negative regulation of cellular senescence
GO:10628; positive regulation of gene expression
GO:45892; negative regulation of transcription, DNA-templated
GO:30154; cell differentiation
GO:7517; muscle organ development
GO:48511; rhythmic process
GO:6357; regulation of transcription by RNA polymerase II
GO:32502; developmental process
GO:45944; positive regulation of transcription by RNA polymerase II
GO:32755; positive regulation of interleukin-6 production
GO:32760; positive regulation of tumor necrosis factor production
GO:122; negative regulation of transcription by RNA polymerase II
GO:45766; positive regulation of angiogenesis
GO:2000147; positive regulation of cell motility
GO:42733; embryonic digit morphogenesis
GO:30500; regulation of bone mineralization
GO:10718; positive regulation of epithelial to mesenchymal transition
GO:3180; aortic valve morphogenesis
GO:45668; negative regulation of osteoblast differentiation
GO:43518; negative regulation of DNA damage response, signal transduction by p53 class mediator
GO:2000144; positive regulation of DNA-templated transcription, initiation
GO:48701; embryonic cranial skeleton morphogenesis
GO:32000; positive regulation of fatty acid beta-oxidation
GO:60363; cranial suture morphogenesis
GO:14067; negative regulation of phosphatidylinositol 3-kinase signaling
GO:2000679; positive regulation of transcription regulatory region DNA binding
GO:61029; eyelid development in camera-type eye
GO:1503; ossification
GO:1649; osteoblast differentiation
GO:1701; in utero embryonic development
GO:1764; neuron migration
GO:1843; neural tube closure
GO:3183; mitral valve morphogenesis
GO:3203; endocardial cushion morphogenesis
GO:3253; cardiac neural crest cell migration involved in outflow tract morphogenesis
GO:30326; embryonic limb morphogenesis
GO:32720; negative regulation of tumor necrosis factor production
GO:33128; negative regulation of histone phosphorylation
GO:35067; negative regulation of histone acetylation
GO:35115; embryonic forelimb morphogenesis
GO:35116; embryonic hindlimb morphogenesis
GO:35137; hindlimb morphogenesis
GO:35359; negative regulation of peroxisome proliferator activated receptor signaling pathway
GO:42473; outer ear morphogenesis
GO:42476; odontogenesis
GO:43066; negative regulation of apoptotic process
GO:43433; negative regulation of DNA-binding transcription factor activity
GO:44092; negative regulation of molecular function
GO:45596; negative regulation of cell differentiation
GO:45843; negative regulation of striated muscle tissue development
GO:48642; negative regulation of skeletal muscle tissue development
GO:48704; embryonic skeletal system morphogenesis
GO:50679; positive regulation of epithelial cell proliferation
GO:60021; roof of mouth development
GO:60348; bone development
GO:60900; embryonic camera-type eye formation
GO:61309; cardiac neural crest cell development involved in outflow tract morphogenesis
GO:71363; cellular response to growth factor stimulus
GO:71639; positive regulation of monocyte chemotactic protein-1 production
GO:2000276; negative regulation of oxidative phosphorylation uncoupler activity
GO:2000780; negative regulation of double-strand break repair
GO:2000793; cell proliferation involved in heart valve development
GO:2000802; positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
